Replies to post #179048 on Amarin Corp Plc (AMRN)

[marzan]

Do you think we see the EVAPORATE abstract tomorrow? Budoff might burst lot of butts then. CHERRY study showed the plaque clearance comparison pics from a mouse both placebo and treatment last time. We might see those from a CVD patient now in EVAPORATE. Shorts are done.

[Pharmacydude]

Jo
I don’t think that “Late breaking clinical trial data” is included in the March 4th date.

EMBARGO - for ACC late breaking clinical trials [ SEE Point #20 ]

https://www.acc.org//~/media/ScientificSessions/ACC19/2018/10/24/ACC19-LBCT-Policies-and-Procedures.pdf?_ga=2.259501320.304269819.1551454443-1480489768.1543439453

20. All authors must read and comply with the ACCF embargo policy, which states that scientific  study results accepted for presentation during the Annual Scientific Session & Expo must not be  released prior to the official embargo time at ACC.19, which is generally time of presentation.  Anyone determined by ACCF to have violated the embargo policies may be withdrawn from the  program and/or otherwise sanctioned. Understanding the embargo time is the sole  responsibility of the investigator. Click here to read the ACC.19 Media Communications Policies  carefully.